Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 469-476

  Brogi, Edi ^a   Schatteman, Gina ^a   Wu, Tiangen ^a   Kim, Elizabeth A ^a   Varticovski, Lyuba ^a   Keyt, Bruce ^b   Isner, Jeffrey M ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

angiogenesis; endothelial cells; flt 1; ischemia; KDR

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; IODINE 125; LACTIC ACID; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; ISCHEMIA; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SCATCHARD PLOT; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0030030668     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118437     Document Type: Article

References (45)

1. Leung, D., G Cachianes, W. Kuang, D. Goeddel, and N Ferrara 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Wash. DC) 246:1306-1312.
2. Songer, D. R , S. J. Galli, A. M. Dvorak, C A. Perruzzi, V S. Harvey, and H. F. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science (Wash. DC) 219.983-985.
3. Connolly, D T., D. M. Heuvelman, R. Nelson, J. V. Olander, B. L. Eppley, J. J. Delfmo, N. R Siegel, R M, Leimgruber, and J. Feder. 1989. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1470-1478.
4. Takeshita, S., L. P. Zheng, E. Brogi, M. Kearney, L. O. Pu, S. Bunting, N. Ferrara, J. F. Symes, and J. M. Isner 1994. Therapeutic angiogenesis: a single ultra-arterial of bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 93 662-670
5. Ferrara, N , K. A. Houch, L. B Jakeman, and D. W Leung 1992 Molecular and biological properties of the vascular endothelial growth factor family of protein. Endocrinol. Rev. 13:18-32
6. Terman, B. I., M. Dougher-Vermazen, M. E. Carrion, D Dimitrov, D. C Armellino, D Gospodarowicz, and P. Bohlen. 1992. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys Res Commun 187:1579-1586.
7. de Vries, C., J. A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L. T. Williams. 1990. The fms-like tyrosine kinase. a receptor for vascular endothelial growth factor. Science (Wash. DC). 87:2628-2632
8. Waltenberger, J., L. Claesson-Welsh, A. Siegbahn, M. Shibuya, and C. H. Heldin 1994. Different signal transduction properties of KDR and flt-1, two receptors for vascular endothelial growth factor. J. Biol Chem. 269:26988-26995.
9. Brown, L F., K. T Yeo, B. Berse, T. K. Yeo, D. R. Senger, H. F. Dvorak, and L. Van de Water. 1992. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocyles during wound healing. J. Exp. Med. 176:1375-1379.
10. Pierce, E. A., R. L. Avery, E. D. Foley, L. P. Aiello, and L. E. H. Smith. 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92:905-909.
11. Hashimoto, E., T. Ogita, T. Nakaoka, R. Matsuoka, A. Takao, and Y. Kira. 1994. Rapid induction of vascular endothelial growth factor by transient ischemia in rat heart. Am. J. Physiol. Heart Circ. Physiol 267:H1948-H1954.
12. Banai, S., D Shweiki, A. Pinson, M. Chandra, G. Lazarovici, and E. Keshet. 1994. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28.1176-1179.
13. Shweiki, D , A. Itin, D. Soffer, and E. Keshet. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-mitiated angiogenesis. Science (Wash. DC). 359:843-845
14. Plate, K. H., G. Breier, H. A. Weich, and W. Risau. 1992 Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.). 359:845-848.
15. Brown, L F , B. Berse, R. W. Jackman, K Tognazzi, A. J. Guidi, H. F. Dvorak, D. R. Senger, J. L. Connolly, and S J. Schnitt. 1995. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 26:86-91.
16. Hatva, E., A. Kaipainen, P. Mentula, J. Jaaskelainen, A. Paetau, M. Haltia. and K Alitalo. 1995. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J. Pathol. 146: 368-378.
17. Brogi, E , T. Wu, A Namiki, and J. M. Isner. 1994. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only Circulation 90:649-652.
18. Iizuki, M., M. Yamauchi, K. Ando, N. Hon, Y. Furusawa, H. Itsukaichi, K. Fukutsu, and H. Morya 1994. Quantitative RT PCR assay detecting the transcriptional induction of vascular endothelial growth factor under hypoxia Biochem Biophys. Res Commun 205:1474-1480.
19. Boucher, Y., and R. K. Jain 1992. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52:5110-5114.
20. Shweiki, D., M. Neeman, A. Itin, and E. Keshet. 1995. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis Proc. Natl Acad Sci. USA 92:768-772.
21. Peters, K. G., C DeVries, and L. T. Williams. 1993. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci USA. 90:8915-8919.
22. Knighton, D R., T K. Hunt, H. Scheuenstuhl, B. J. Halliday, Z. Werb, and M. J Banda. 1983 Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science (Wash. DC) 221:1283-1285.
23. Banters, C., T. Asahara, L. Zheng, S. Takeshita, S. Bunting, N. Ferrara, J F. Symes, and J. M, Isner. 1995. Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J. Vasc Surg. 21:314-325.
24. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C R. Minick 1973. Culture of human endothelial cells derived from umbilical veins. J. Clin Invest. 52: 2745-2756
25. Pickering, J G., L. Weir, K. Rosenfield, J. Stetz, J. Jekanowski, and J. M. Isner. 1992. Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. J. Am. Coll. Cardiol. 20:1430-1439.
26. Whitman, M., D. R. Kaplan, B. Schaffhausen, L. Cantley, and T. M. Roberts 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature. (Lond.). 315:239-242.
27. Jakeman, L. B., J. Winer, G. L. Bennett, C. A Altar, and N Ferrara. 1992. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89:244-253.
28. Bikfalvi, A., C. Sauzeau, H. Moukadiri, J. Maclouf, N. Busso, M. Bryckaert, J. Plouet, and G. Tobelem. 1991. Interaction of vasculotropin/vascular endothehal cell growth factor with human umbilical vein endothelial cell: binding, internalization, degradation, and biological effects. J. Cell. Physiol. 149:50-59
29. Muthukrishnan, L., E. Warder, and P. L. McNeil. 1991. Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. Cell. Physiol. 148:1-16
30. Assoian, R. K. 1994. Biphasic effects of type β transforming growth factor on epidermal growth factor receptors in NRK fibroblasts. J. Biol. Chem 260:9613-9617.
31. Ghezzi. P , C. A Dinarello, M. Bianchi, M. E. Rosandich, J. E. Repine, and C. W. White. 1991. Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 3:189-194.
32. Tuder, R. M., B. E Flook, and N. F Voelkel 1995. Increased gene expression of VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or chronic hypoxia J. Clin. Invest. 95:1798-1807.
33. Wizigmann-Voos, S., G. Breier, W. Risau, and K. H Plate. 1995. Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 55. 1358-1364
34. Plate, K. H., G. Breier, H. A. Weich, H D. Mennel, and W. Risau. 1994. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors., distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520-529.
35. Warren, R S., H. Yuan, M R. Math, N. A. Gillett. and N. Ferrara. 1995. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin. Invest. 95: 1789-1797.
36. Page, C , M. Rose, M. Yacoub, and R. Pigott. 1992. Antigenic heterogeneity of vascular endothelium Am J Pathol. 141:673-683.
37. Thieme, H., L. P. Aiello, H. Takagi, N. Ferrara and G. L. King. 1995. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44.98-103.
38. Park, J E , H. H. Chen, J Winer, K. A. Houck, and N Ferrara. 1994 Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Fit-1 but not to Flk-1/ KDR. J. Biol. Chem. 269.25646-25654.
39. Millauer, B., L. K. Shawver, K. H. Plate, W. Risau, and A. Ullrich. 1994 Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond ). 367:576-579
40. Millauer, B., S. Wizigmann-Voos, H. Schnurch, R. Martinez, N. P. H. Moller, W Risau, and A. Ullrich 1993 High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:835-846.
41. Pepper, M. S., N. Ferrara, L. Orci. and R. Montesano. 1992. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro Biochem. Biophys, Res. Commun 189:824-831.
42. Goto, F., K. Goto, K. Weindel, and J. Folkman. 1993 Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation of bovine capillary endothelial cells within collagen gels. Lab. Invest 69:508-517.
43. Falcone, D. J., T. A. McCaffrey, A. Haimovitz-Friedman, and M. Garcia. 1993 Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J. Cell. Physiol. 155:595-605.
44. Frater-Schroder, M., W. Risau, R. Hallmann, P. Gautschi, and P. Bohlen. 1987 Tumor necrosis factor α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Prot. Natl Acad. Sci USA. 84:5277-5281.
45. Sigegrist, W., S. Stutz, and A. N Eberle 1994. Homologous and heterologous regulation of α-melanocyte stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res 54:2604-2610.